Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation

Despite therapeutic advances, effective treatments for chronic constipation remain an unmet need. The vibrating capsule is a nonpharmacologic, orally ingested, programmable capsule that vibrates intraluminally to induce bowel movements. We aimed to determine the efficacy and safety of the vibrating...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Gastroenterology (New York, N.Y. 1943) N.Y. 1943), 2023-06, Vol.164 (7), p.1202-1210.e6
Hauptverfasser: Rao, Satish S.C., Quigley, Eamonn M.M., Chey, William D., Sharma, Amol, Lembo, Anthony J.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1210.e6
container_issue 7
container_start_page 1202
container_title Gastroenterology (New York, N.Y. 1943)
container_volume 164
creator Rao, Satish S.C.
Quigley, Eamonn M.M.
Chey, William D.
Sharma, Amol
Lembo, Anthony J.
description Despite therapeutic advances, effective treatments for chronic constipation remain an unmet need. The vibrating capsule is a nonpharmacologic, orally ingested, programmable capsule that vibrates intraluminally to induce bowel movements. We aimed to determine the efficacy and safety of the vibrating capsule in patients with chronic constipation. We conducted a phase 3, double-blind, placebo-controlled trial of patients with chronic constipation, who were randomized to receive either a vibrating or placebo capsule, once daily, 5 days a week for 8 weeks. The primary efficacy end points were an increase of 1 or more complete spontaneous bowel movements per week (CSBM1 responder) or 2 or more CSBMs per week (CSBM2) from baseline during at least 6 of the 8 weeks. Safety analyses were performed. Among 904 patients screened, 312 were enrolled. A greater percentage of patients receiving the vibrating capsule achieved both primary efficacy end points compared with placebo (39.3% vs 22.1%, P = .001 for CSBM1; 22.7% vs 11.4% P = .008 for CSBM2). Significantly greater improvements were seen with the vibrating capsule for the secondary end points of straining, stool consistency, and quality-of-life measures compared with placebo. Adverse events were mild, gastrointestinal in nature, and similar between groups, except that a mild vibrating sensation was reported by 11% of patients in the vibrating capsule group, but none withdrew from the trial. In patients with chronic constipation, the vibrating capsule was superior to placebo in improving bowel symptoms and quality of life. The vibrating capsule was safe and well tolerated. (Clinical trials.gov, Number: NCT03879239) [Display omitted] The vibrating capsule is a novel, drug-free capsule device that significantly improved bowel symptoms and quality of life in patients with chronic constipation and was safe, in a randomized clinical trial.
doi_str_mv 10.1053/j.gastro.2023.02.013
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2780080580</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S001650852300149X</els_id><sourcerecordid>2780080580</sourcerecordid><originalsourceid>FETCH-LOGICAL-c362t-6ce57681280b8919ced961f109b06f32ddf8acb46770fcc8132d54f960d642b03</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMoWj_-gUiOXnadJN1s9iLI4hcUFKmCp5DNJm3KdlOTraC_3pRWj54Ghud9h3kQOieQEyjY1SKfqTgEn1OgLAeaA2F7aEQKKjIAQvfRKA2eFSCKI3Qc4wIAKibIITpiXFDKSjJC7y-qb_3SfZsWP3dKm8Znte9Tb9dtVnMVDWZ4GpzqsLf4zTVBDa6f4Vqt4roz2PqA63nwvdM4JePgVgnw_Sk6sKqL5mw3T9Dr3e20fsgmT_eP9c0k04zTIePaFCUXhApoREUqbdqKE0ugaoBbRtvWCqWbMS9LsFoLklbF2FYcWj6mDbATdLntXQX_sTZxkEsXtek61Ru_jpKWAkBAITboeIvq4GMMxspVcEsVviQBuZEqF3IrVW6kSqAySU2xi92FdbM07V_o12ICrreASX9-OhNk1M706RUXjB5k693_F34AqQaJrA</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2780080580</pqid></control><display><type>article</type><title>Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><source>Alma/SFX Local Collection</source><creator>Rao, Satish S.C. ; Quigley, Eamonn M.M. ; Chey, William D. ; Sharma, Amol ; Lembo, Anthony J.</creator><creatorcontrib>Rao, Satish S.C. ; Quigley, Eamonn M.M. ; Chey, William D. ; Sharma, Amol ; Lembo, Anthony J.</creatorcontrib><description>Despite therapeutic advances, effective treatments for chronic constipation remain an unmet need. The vibrating capsule is a nonpharmacologic, orally ingested, programmable capsule that vibrates intraluminally to induce bowel movements. We aimed to determine the efficacy and safety of the vibrating capsule in patients with chronic constipation. We conducted a phase 3, double-blind, placebo-controlled trial of patients with chronic constipation, who were randomized to receive either a vibrating or placebo capsule, once daily, 5 days a week for 8 weeks. The primary efficacy end points were an increase of 1 or more complete spontaneous bowel movements per week (CSBM1 responder) or 2 or more CSBMs per week (CSBM2) from baseline during at least 6 of the 8 weeks. Safety analyses were performed. Among 904 patients screened, 312 were enrolled. A greater percentage of patients receiving the vibrating capsule achieved both primary efficacy end points compared with placebo (39.3% vs 22.1%, P = .001 for CSBM1; 22.7% vs 11.4% P = .008 for CSBM2). Significantly greater improvements were seen with the vibrating capsule for the secondary end points of straining, stool consistency, and quality-of-life measures compared with placebo. Adverse events were mild, gastrointestinal in nature, and similar between groups, except that a mild vibrating sensation was reported by 11% of patients in the vibrating capsule group, but none withdrew from the trial. In patients with chronic constipation, the vibrating capsule was superior to placebo in improving bowel symptoms and quality of life. The vibrating capsule was safe and well tolerated. (Clinical trials.gov, Number: NCT03879239) [Display omitted] The vibrating capsule is a novel, drug-free capsule device that significantly improved bowel symptoms and quality of life in patients with chronic constipation and was safe, in a randomized clinical trial.</description><identifier>ISSN: 0016-5085</identifier><identifier>EISSN: 1528-0012</identifier><identifier>DOI: 10.1053/j.gastro.2023.02.013</identifier><identifier>PMID: 36822371</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Bowel Symptoms ; Constipation ; Constipation - diagnosis ; Constipation - drug therapy ; Defecation ; Double-Blind Method ; Humans ; Quality of Life ; Treatment ; Treatment Outcome ; Vibrating Capsule</subject><ispartof>Gastroenterology (New York, N.Y. 1943), 2023-06, Vol.164 (7), p.1202-1210.e6</ispartof><rights>2023</rights><rights>Copyright © 2023. Published by Elsevier Inc.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c362t-6ce57681280b8919ced961f109b06f32ddf8acb46770fcc8132d54f960d642b03</citedby><cites>FETCH-LOGICAL-c362t-6ce57681280b8919ced961f109b06f32ddf8acb46770fcc8132d54f960d642b03</cites><orcidid>0000-0002-4446-8452</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1053/j.gastro.2023.02.013$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/36822371$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Rao, Satish S.C.</creatorcontrib><creatorcontrib>Quigley, Eamonn M.M.</creatorcontrib><creatorcontrib>Chey, William D.</creatorcontrib><creatorcontrib>Sharma, Amol</creatorcontrib><creatorcontrib>Lembo, Anthony J.</creatorcontrib><title>Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation</title><title>Gastroenterology (New York, N.Y. 1943)</title><addtitle>Gastroenterology</addtitle><description>Despite therapeutic advances, effective treatments for chronic constipation remain an unmet need. The vibrating capsule is a nonpharmacologic, orally ingested, programmable capsule that vibrates intraluminally to induce bowel movements. We aimed to determine the efficacy and safety of the vibrating capsule in patients with chronic constipation. We conducted a phase 3, double-blind, placebo-controlled trial of patients with chronic constipation, who were randomized to receive either a vibrating or placebo capsule, once daily, 5 days a week for 8 weeks. The primary efficacy end points were an increase of 1 or more complete spontaneous bowel movements per week (CSBM1 responder) or 2 or more CSBMs per week (CSBM2) from baseline during at least 6 of the 8 weeks. Safety analyses were performed. Among 904 patients screened, 312 were enrolled. A greater percentage of patients receiving the vibrating capsule achieved both primary efficacy end points compared with placebo (39.3% vs 22.1%, P = .001 for CSBM1; 22.7% vs 11.4% P = .008 for CSBM2). Significantly greater improvements were seen with the vibrating capsule for the secondary end points of straining, stool consistency, and quality-of-life measures compared with placebo. Adverse events were mild, gastrointestinal in nature, and similar between groups, except that a mild vibrating sensation was reported by 11% of patients in the vibrating capsule group, but none withdrew from the trial. In patients with chronic constipation, the vibrating capsule was superior to placebo in improving bowel symptoms and quality of life. The vibrating capsule was safe and well tolerated. (Clinical trials.gov, Number: NCT03879239) [Display omitted] The vibrating capsule is a novel, drug-free capsule device that significantly improved bowel symptoms and quality of life in patients with chronic constipation and was safe, in a randomized clinical trial.</description><subject>Bowel Symptoms</subject><subject>Constipation</subject><subject>Constipation - diagnosis</subject><subject>Constipation - drug therapy</subject><subject>Defecation</subject><subject>Double-Blind Method</subject><subject>Humans</subject><subject>Quality of Life</subject><subject>Treatment</subject><subject>Treatment Outcome</subject><subject>Vibrating Capsule</subject><issn>0016-5085</issn><issn>1528-0012</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2023</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNp9kE1LAzEQhoMoWj_-gUiOXnadJN1s9iLI4hcUFKmCp5DNJm3KdlOTraC_3pRWj54Ghud9h3kQOieQEyjY1SKfqTgEn1OgLAeaA2F7aEQKKjIAQvfRKA2eFSCKI3Qc4wIAKibIITpiXFDKSjJC7y-qb_3SfZsWP3dKm8Znte9Tb9dtVnMVDWZ4GpzqsLf4zTVBDa6f4Vqt4roz2PqA63nwvdM4JePgVgnw_Sk6sKqL5mw3T9Dr3e20fsgmT_eP9c0k04zTIePaFCUXhApoREUqbdqKE0ugaoBbRtvWCqWbMS9LsFoLklbF2FYcWj6mDbATdLntXQX_sTZxkEsXtek61Ru_jpKWAkBAITboeIvq4GMMxspVcEsVviQBuZEqF3IrVW6kSqAySU2xi92FdbM07V_o12ICrreASX9-OhNk1M706RUXjB5k693_F34AqQaJrA</recordid><startdate>202306</startdate><enddate>202306</enddate><creator>Rao, Satish S.C.</creator><creator>Quigley, Eamonn M.M.</creator><creator>Chey, William D.</creator><creator>Sharma, Amol</creator><creator>Lembo, Anthony J.</creator><general>Elsevier Inc</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0002-4446-8452</orcidid></search><sort><creationdate>202306</creationdate><title>Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation</title><author>Rao, Satish S.C. ; Quigley, Eamonn M.M. ; Chey, William D. ; Sharma, Amol ; Lembo, Anthony J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c362t-6ce57681280b8919ced961f109b06f32ddf8acb46770fcc8132d54f960d642b03</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2023</creationdate><topic>Bowel Symptoms</topic><topic>Constipation</topic><topic>Constipation - diagnosis</topic><topic>Constipation - drug therapy</topic><topic>Defecation</topic><topic>Double-Blind Method</topic><topic>Humans</topic><topic>Quality of Life</topic><topic>Treatment</topic><topic>Treatment Outcome</topic><topic>Vibrating Capsule</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Rao, Satish S.C.</creatorcontrib><creatorcontrib>Quigley, Eamonn M.M.</creatorcontrib><creatorcontrib>Chey, William D.</creatorcontrib><creatorcontrib>Sharma, Amol</creatorcontrib><creatorcontrib>Lembo, Anthony J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Rao, Satish S.C.</au><au>Quigley, Eamonn M.M.</au><au>Chey, William D.</au><au>Sharma, Amol</au><au>Lembo, Anthony J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation</atitle><jtitle>Gastroenterology (New York, N.Y. 1943)</jtitle><addtitle>Gastroenterology</addtitle><date>2023-06</date><risdate>2023</risdate><volume>164</volume><issue>7</issue><spage>1202</spage><epage>1210.e6</epage><pages>1202-1210.e6</pages><issn>0016-5085</issn><eissn>1528-0012</eissn><abstract>Despite therapeutic advances, effective treatments for chronic constipation remain an unmet need. The vibrating capsule is a nonpharmacologic, orally ingested, programmable capsule that vibrates intraluminally to induce bowel movements. We aimed to determine the efficacy and safety of the vibrating capsule in patients with chronic constipation. We conducted a phase 3, double-blind, placebo-controlled trial of patients with chronic constipation, who were randomized to receive either a vibrating or placebo capsule, once daily, 5 days a week for 8 weeks. The primary efficacy end points were an increase of 1 or more complete spontaneous bowel movements per week (CSBM1 responder) or 2 or more CSBMs per week (CSBM2) from baseline during at least 6 of the 8 weeks. Safety analyses were performed. Among 904 patients screened, 312 were enrolled. A greater percentage of patients receiving the vibrating capsule achieved both primary efficacy end points compared with placebo (39.3% vs 22.1%, P = .001 for CSBM1; 22.7% vs 11.4% P = .008 for CSBM2). Significantly greater improvements were seen with the vibrating capsule for the secondary end points of straining, stool consistency, and quality-of-life measures compared with placebo. Adverse events were mild, gastrointestinal in nature, and similar between groups, except that a mild vibrating sensation was reported by 11% of patients in the vibrating capsule group, but none withdrew from the trial. In patients with chronic constipation, the vibrating capsule was superior to placebo in improving bowel symptoms and quality of life. The vibrating capsule was safe and well tolerated. (Clinical trials.gov, Number: NCT03879239) [Display omitted] The vibrating capsule is a novel, drug-free capsule device that significantly improved bowel symptoms and quality of life in patients with chronic constipation and was safe, in a randomized clinical trial.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>36822371</pmid><doi>10.1053/j.gastro.2023.02.013</doi><orcidid>https://orcid.org/0000-0002-4446-8452</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0016-5085
ispartof Gastroenterology (New York, N.Y. 1943), 2023-06, Vol.164 (7), p.1202-1210.e6
issn 0016-5085
1528-0012
language eng
recordid cdi_proquest_miscellaneous_2780080580
source MEDLINE; Elsevier ScienceDirect Journals Complete; Alma/SFX Local Collection
subjects Bowel Symptoms
Constipation
Constipation - diagnosis
Constipation - drug therapy
Defecation
Double-Blind Method
Humans
Quality of Life
Treatment
Treatment Outcome
Vibrating Capsule
title Randomized Placebo-Controlled Phase 3 Trial of Vibrating Capsule for Chronic Constipation
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-25T08%3A50%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Randomized%20Placebo-Controlled%20Phase%203%20Trial%20of%20Vibrating%20Capsule%20for%20Chronic%20Constipation&rft.jtitle=Gastroenterology%20(New%20York,%20N.Y.%201943)&rft.au=Rao,%20Satish%20S.C.&rft.date=2023-06&rft.volume=164&rft.issue=7&rft.spage=1202&rft.epage=1210.e6&rft.pages=1202-1210.e6&rft.issn=0016-5085&rft.eissn=1528-0012&rft_id=info:doi/10.1053/j.gastro.2023.02.013&rft_dat=%3Cproquest_cross%3E2780080580%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2780080580&rft_id=info:pmid/36822371&rft_els_id=S001650852300149X&rfr_iscdi=true